Options
Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment
Journal
Alimentary pharmacology & therapeutics
Journal Volume
55
Journal Issue
4
Pages
434
End Page
445
Date Issued
2022-02
Author(s)
Peng, Cheng-Yuan
Kao, Wei-Yu
Yang, Sheng-Shun
Shih, Yu-Lueng
Lee, Chih-Yuan
Chang, Chun-Chao
Wu, Jo-Hsuan
Abstract
Data are limited regarding the risk of hepatitis C virus (HCV) reinfection after treatment-induced sustained virologic response (SVR) in patients on haemodialysis.
Subjects
TREATMENT-NAIVE PATIENTS; LOW-DOSE RIBAVIRIN; PEGINTERFERON ALPHA-2A; RECEIVING HEMODIALYSIS; PEGYLATED INTERFERON; WEEKS POSTTREATMENT; INFECTION; RISK; HCV; ELIMINATION
SDGs
Publisher
WILEY
Type
journal article